A long-overlooked metabolic pathway for isoprenoid biosynthesis, the mevalonateindependent methylerythritol phosphate (MEP) pathway, is present in many bacteria and in the chloroplasts of all phototrophic organisms. It represents an alternative to the well-known mevalonate pathway, which is present in animals, fungi, plant cytoplasm, archaebacteria, and some eubacteria. This contribution summarizes key steps of its elucidation and the state-ofthe-art knowledge of this biosynthetic pathway, which represents a novel target for antibacterial and antiparasitic drugs.